Dynavax Technologies Corp. (DVAX)

Dynavax (DVAX) Stock Price & Analysis


DVAX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$9.42 - $15.15
Previous Close$13.79
Average Volume (3M)1.56M
Market Cap
Enterprise Value$1.32B
Total Cash (Recent Filing)$720.42M
Total Debt (Recent Filing)$253.09M
Price to Earnings (P/E)35.9
Feb 27, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.38
Shares Outstanding129,260,850
10 Day Avg. Volume1,315,942
30 Day Avg. Volume1,555,217
Standard Deviation0.25
Financial Highlights & Ratios
Price to Book (P/B)2.96
Price to Sales (P/S)2.47
Price to Cash Flow (P/CF)14.30
P/FCF Ratio13.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.61
Enterprise Value/Gross Profit2.86
Enterprise Value/Ebitda26.40
Price Target Upside95.10% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3



Ownership Overview

25.69% Mutual Funds
50.93% Other Institutional Investors
22.46% Public Companies and
Individual Investors


What was Dynavax Technologies Corp.’s price range in the past 12 months?
Dynavax Technologies Corp. lowest stock price was $9.42 and its highest was $15.15 in the past 12 months.
    What is Dynavax Technologies Corp.’s market cap?
    Currently, no data Available
    When is Dynavax Technologies Corp.’s upcoming earnings report date?
    Dynavax Technologies Corp.’s upcoming earnings report date is Feb 27, 2024 which is in 85 days.
      How were Dynavax Technologies Corp.’s earnings last quarter?
      Dynavax Technologies Corp. released its earnings results on Nov 02, 2023. The company reported $0.1 earnings per share for the quarter, beating the consensus estimate of -$0.038 by $0.138.
        Is Dynavax Technologies Corp. overvalued?
        According to Wall Street analysts Dynavax Technologies Corp.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Dynavax Technologies Corp. pay dividends?
          Dynavax Technologies Corp. does not currently pay dividends.
          What is Dynavax Technologies Corp.’s EPS estimate?
          Dynavax Technologies Corp.’s EPS estimate is -$0.03.
            How many shares outstanding does Dynavax Technologies Corp. have?
            Dynavax Technologies Corp. has 129,260,850 shares outstanding.
              What happened to Dynavax Technologies Corp.’s price movement after its last earnings report?
              Dynavax Technologies Corp. reported an EPS of $0.1 in its last earnings report, beating expectations of -$0.038. Following the earnings report the stock price went up 1.066%.
                Which hedge fund is a major shareholder of Dynavax Technologies Corp.?
                Among the largest hedge funds holding Dynavax Technologies Corp.’s share is Fisher Asset Management LLC. It holds Dynavax Technologies Corp.’s shares valued at 25M.


                  Company Description

                  Dynavax Technologies Corp.

                  Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.


                  Top 5 ETFs holding DVAX

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  Vanguard Russell 3000 ETF
                  SPDR S&P 1500 Value Tilt ETF
                  Invesco S&P US Total Market ESG Tilt Index ETF Trust Units -CAD Hedged-
                  Up to five ETFs with an Outperform Smart Score that hold DVAX. The ETFs are listed according to market value of DVAX within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Inovio Pharmaceuticals
                  BioNTech SE

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis